Rein Therapeutics, Inc. Common Stock
$0.9601
USD
Last updated on --.
24h volume721.49K
24h highest1.0400 USD
24h lowest0.90120 USD
24h Price movement+3.73%
RNTX recent prices
24 Hours
+3.73%+$0.0345
30 days
-20.47%-$0.2375
60 days
-40.48%-$0.6275
90 days
-29.03%-$0.3774
Key data
Previous close0.92560 USD
Market cap80.67M USD
Volume721.49K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.59000 USD
Net income (FY)-50.21M USD
Revenue (FY)--
Last report dateMay 15, 2026
About Rein Therapeutics, Inc. Common Stock
HeadquartersAUSTIN
Employees (FY)10.00
Net income per employee (FY)-5.02M USD
Listed onNasdaq
RNTX conversion tables
 |  |
|---|---|
| 0.5 RNTX | 0.48005 USD |
| 1 RNTX | 0.9601 USD |
| 5 RNTX | 4.800 USD |
| 10 RNTX | 9.601 USD |
| |
|---|---|
| 0.5 USD | 0.52078 RNTX |
| 1 USD | 1.041 RNTX |
| 5 USD | 5.207 RNTX |
| 10 USD | 10.41 RNTX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
RNTX is trading at $0.9601, +3.73% over the last 24 hours. Track live moves on the price chart at the top of this page.
The RNTX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. RNTX is currently trading at $0.9601, +3.73% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on RNTX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. RNTX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from RNTX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against RNTX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Rein Therapeutics, Inc. Common Stock's market cap is currently 80.67M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume721.49K
24h highest1.0400 USD
24h lowest0.90120 USD
24h Price movement+3.73%
Start trade with RNTX Perpetual
Sign up to trade